Sander Capital Advisors Inc Johnson & Johnson Transaction History

Sander Capital Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$137.11 - $157.38 $185,098 - $212,463	-1,350 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$128.81 - $155.51 $173,893 - $209,938	1,350 New	1,350 $190,000
Q1 2020 May 06, 2020	SELL	$111.14 - $153.99 $250,065 - $346,477	-2,250 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$131.15 - $144.24 $157,380 - $173,088	-1,200 Reduced 34.78%	2,250 $313,000
Q2 2018 Aug 07, 2018	SELL	$119.4 - $131.76 $77,610 - $85,644	-650 Reduced 15.85%	3,450 $419,000
Q1 2018 May 04, 2018	SELL	$125.1 - $148.14 $112,590 - $133,326	-900 Reduced 18.0%	4,100 $528,000
Q4 2017 Mar 05, 2018	BUY	$131.22 - $143.62 $656,100 - $718,100	5,000	5,000 $700,000

4,271

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Sander Capital Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Sander Capital Advisors Inc with notifications on news.